Caseware UK (AP4) 2023.0.135 2023.0.135 2024-04-302024-04-30false2023-05-01falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.86101 - Hospital activities44truefalse 04409270 2023-05-01 2024-04-30 04409270 2022-05-01 2023-04-30 04409270 2024-04-30 04409270 2023-04-30 04409270 2022-05-01 04409270 c:Director1 2023-05-01 2024-04-30 04409270 d:MotorVehicles 2023-05-01 2024-04-30 04409270 d:MotorVehicles 2024-04-30 04409270 d:MotorVehicles 2023-04-30 04409270 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 04409270 d:FurnitureFittings 2023-05-01 2024-04-30 04409270 d:FurnitureFittings 2024-04-30 04409270 d:FurnitureFittings 2023-04-30 04409270 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 04409270 d:ComputerEquipment 2023-05-01 2024-04-30 04409270 d:ComputerEquipment 2024-04-30 04409270 d:ComputerEquipment 2023-04-30 04409270 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 04409270 d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 04409270 d:Goodwill 2024-04-30 04409270 d:Goodwill 2023-04-30 04409270 d:CurrentFinancialInstruments 2024-04-30 04409270 d:CurrentFinancialInstruments 2023-04-30 04409270 d:Non-currentFinancialInstruments 2024-04-30 04409270 d:Non-currentFinancialInstruments 2023-04-30 04409270 d:CurrentFinancialInstruments d:WithinOneYear 2024-04-30 04409270 d:CurrentFinancialInstruments d:WithinOneYear 2023-04-30 04409270 d:Non-currentFinancialInstruments d:AfterOneYear 2024-04-30 04409270 d:Non-currentFinancialInstruments d:AfterOneYear 2023-04-30 04409270 d:ShareCapital 2024-04-30 04409270 d:ShareCapital 2023-04-30 04409270 d:RetainedEarningsAccumulatedLosses 2024-04-30 04409270 d:RetainedEarningsAccumulatedLosses 2023-04-30 04409270 d:AcceleratedTaxDepreciationDeferredTax 2024-04-30 04409270 d:AcceleratedTaxDepreciationDeferredTax 2023-04-30 04409270 c:OrdinaryShareClass1 2023-05-01 2024-04-30 04409270 c:OrdinaryShareClass1 2024-04-30 04409270 c:OrdinaryShareClass1 2023-04-30 04409270 c:OrdinaryShareClass2 2023-05-01 2024-04-30 04409270 c:OrdinaryShareClass2 2024-04-30 04409270 c:OrdinaryShareClass2 2023-04-30 04409270 c:OrdinaryShareClass3 2023-05-01 2024-04-30 04409270 c:OrdinaryShareClass3 2024-04-30 04409270 c:OrdinaryShareClass3 2023-04-30 04409270 c:OrdinaryShareClass4 2023-05-01 2024-04-30 04409270 c:OrdinaryShareClass4 2024-04-30 04409270 c:OrdinaryShareClass4 2023-04-30 04409270 c:FRS102 2023-05-01 2024-04-30 04409270 c:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 04409270 c:FullAccounts 2023-05-01 2024-04-30 04409270 c:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 04409270 d:HirePurchaseContracts d:WithinOneYear 2024-04-30 04409270 d:HirePurchaseContracts d:WithinOneYear 2023-04-30 04409270 d:HirePurchaseContracts d:BetweenOneFiveYears 2024-04-30 04409270 d:HirePurchaseContracts d:BetweenOneFiveYears 2023-04-30 04409270 2 2023-05-01 2024-04-30 04409270 e:PoundSterling 2023-05-01 2024-04-30 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 04409270










THE WINDSOR EYE CLINIC LIMITED








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024

 
THE WINDSOR EYE CLINIC LIMITED
REGISTERED NUMBER: 04409270

BALANCE SHEET
AS AT 30 APRIL 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
202,525
188,891

  
202,525
188,891

Current assets
  

Debtors: amounts falling due within one year
 6 
1,009,495
873,306

Cash at bank and in hand
 7 
2,612
4,937

  
1,012,107
878,243

Current liabilities
  

Creditors: amounts falling due within one year
 8 
(256,905)
(173,574)

Total assets less current liabilities
  
 
 
957,727
 
 
893,560

Creditors: amounts falling due after more than one year
 9 
(34,062)
(76,994)

Provisions for liabilities
  

Deferred tax
 11 
(50,631)
(47,223)

  
 
 
(50,631)
 
 
(47,223)

Net assets
  
873,034
769,343


Capital and reserves
  

Called up share capital 
 12 
1
1

Profit and loss account
  
873,033
769,342

  
873,034
769,343


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

Page 1

 
THE WINDSOR EYE CLINIC LIMITED
REGISTERED NUMBER: 04409270

BALANCE SHEET (CONTINUED)
AS AT 30 APRIL 2024

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
S Kheterpal
Director

Date: 31 January 2025

The notes on pages 3 to 11 form part of these financial statements.

Page 2

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1.


General information

The Windsor Eye Clinic Limited is a private company, limited by share capital and incorporated in England and Wales. 
The company's registered office address is 2 Communications Road, Greenham Business Park, Greenham, Newbury, Berkshire, RG19 6AB.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.7

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.8

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Page 4

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.9

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on both a straight line and reducing balance basis.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
Reducing balance
Fixtures and fittings
-
25%
Reducing balance
Computer equipment
-
33%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.12

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.13

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 5

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.14

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.15

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

 
2.16

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 4 (2023 - 4).

Page 6

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

4.


Intangible assets




Goodwill

£



Cost


At 1 May 2023
100,000



At 30 April 2024

100,000



Amortisation


At 1 May 2023
100,000



At 30 April 2024

100,000



Net book value



At 30 April 2024
-



At 30 April 2023
-



Page 7

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

5.


Tangible fixed assets





Motor vehicles
Fixtures and fittings
Computer equipment
Total

£
£
£
£



Cost or valuation


At 1 May 2023
80,330
354,484
40,419
475,233


Additions
-
77,831
1,345
79,176



At 30 April 2024

80,330
432,315
41,764
554,409



Depreciation


At 1 May 2023
69,880
189,403
27,059
286,342


Charge for the year on owned assets
2,613
55,450
7,479
65,542



At 30 April 2024

72,493
244,853
34,538
351,884



Net book value



At 30 April 2024
7,837
187,462
7,226
202,525



At 30 April 2023
10,450
165,081
13,360
188,891

The net book value of tangible fixed asset includes £46,792 (2023: £53,055) in respect of assets held under finance leases or hire purchase contracts. The depreciation charge in respect of such assets amounted to £14,264 (2023: £17,685) for the year.


6.


Debtors

2024
2023
£
£


Trade debtors
139,050
109,703

Other debtors
840,036
757,177

Prepayments and accrued income
30,409
6,426

1,009,495
873,306



7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
2,612
4,937


Page 8

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
18,000
18,000

Other loans
52,000
12,000

Trade creditors
43,823
15,793

Corporation tax
107,641
88,590

Other taxation and social security
1,651
-

Obligations under finance lease and hire purchase contracts
21,874
22,049

Accruals and deferred income
11,916
17,142

256,905
173,574


Obligations under finance lease and hire purchase contracts are secured against the assets to which they relate.


9.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
19,500
37,500

Other loans
8,437
13,770

Obligations under finance leases and hire purchase contracts
6,125
25,724

34,062
76,994


Obligations under finance lease and hire purchase contracts are secured against the assets to which they relate.


10.


Hire purchase and finance leases


Minimum lease payments under hire purchase fall due as follows:

2024
2023
£
£



Within one year
21,874
22,049

Between 1-5 years
6,125
25,724

27,999
47,773


11.


Deferred taxation

Page 9

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024
 
11.Deferred taxation (continued)




2024
2023


£

£



At beginning of year
(47,223)
(40,523)


Charged to profit or loss
(3,408)
(6,700)



At end of year
(50,631)
(47,223)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(50,631)
(47,223)

(50,631)
(47,223)


12.


Share capital

2024
2023
£
£
Authorised, allotted, called up and fully paid



51 (2023 - 51) Ordinary A shares shares of £0.01 each
0.51
0.51
31 (2023 - 31) Ordinary B shares shares of £0.01 each
0.31
0.31
9 (2023 - 9) Ordinary C shares shares of £0.01 each
0.09
0.09
9 (2023 - 9) Ordinary D shares shares of £0.01 each
0.09
0.09

1.00

1.00



13.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company  in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £34,470 (2023 - £8,670).

Page 10

 
THE WINDSOR EYE CLINIC LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

14.


Related party transactions

Dividends totalling £169,620 (2023: £224,100) were paid in the year in respect of shares held by the company's director and close family members.
Included within other debtors at the year end is a balance of £168,613 (2023: £156,713) due from WEC Properties Limited, a company under common control.
Included within other debtors at the year end is a balance of £337,110 (2023: £307,791) due from WEC Holdings Limited, a company under common control.
Included within other debtors at the year end is a balance of £258,793 (2023: £222,188) due from S Kheterpal director of the company. No amounts were repaid in the year and a further amount of £36,495 was borrowed in the year.


15.


Controlling party

The company is controlled by its director.


Page 11